Hyperoxaluria (DBCOND0018899)

Identifiers

Synonyms

Primary hyperoxaluria / Hyperoxaluria (disorder)

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT01127087	Oxazyme in Patients With Hyperoxaluria	No drug interventions	treatment	1 / 2	completed
NCT00283387	Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria	Betaine Lactose	treatment	2	completed
NCT06578754	Validation Test for Plasma Oxalate Level in a Biochemical Laboratory at the Galilee Medical Center	No drug interventions	Not Available	Not Available	not_yet_recruiting
NCT02780297	Prospective Research Rare Kidney Stones (ProRKS)	No drug interventions	Not Available	Not Available	recruiting
NCT03095885	A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria	No drug interventions	basic_science	Not Available	completed
NCT05443932	Dapagliflozin and Hydrochlorothiazide in Recurring Kidney Stone Patients	Dapagliflozin Hydrochlorothiazide	prevention	4	not_yet_recruiting
NCT00199459	Proteomic Study of Urinary Stone Disease	No drug interventions	Not Available	Not Available	completed
NCT04571359	Spot Urine Oxalate to Creatinine Ratio and 24 Hours Urinary Oxalate	No drug interventions	Not Available	Not Available	completed
NCT00587041	Use of Oral Probiotics to Reduce Urinary Oxalate Excretion	No drug interventions	treatment	1 / 2	completed
NCT06138327	A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria	5-[[trans-4-[4-(trifluoromethoxy)phenyl]cyclohexyl]oxy]-1H-1,2,3-triazole-4-carboxylic acid	treatment	1	withdrawn
NCT02289755	Evaluating ALLN-177 for Reducing Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With Hyperoxaluria	Reloxaliase	treatment	2	completed
NCT02038543	Hydroxyproline Influence on Oxalate Metabolism	Hydroxyproline Leucine	treatment	1 / 2	completed
NCT02503345	Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney Stones	Reloxaliase	treatment	2	completed
NCT02547805	Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days	Reloxaliase	treatment	2	completed
NCT00280215	Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria	Angiotensin II Lisinopril Losartan	prevention	3	withdrawn
NCT04756024	Reference Interval of Spot Urinary Oxalate to Creatinine Ratio in Children	No drug interventions	Not Available	Not Available	completed
NCT04119765	Plasma Oxalate in Patient With Short Bowel	No drug interventions	Not Available	Not Available	completed
NCT00588120	Enteric Oxalate Absorption Study in Unclassified Hyperoxaluria	No drug interventions	diagnostic	1	completed
NCT02404701	Effect of Over-the-counter Dietary Supplements on Kidney Stone Risk	No drug interventions	basic_science	Not Available	completed
NCT06481150	A Novel Approach for Reducing Hyperoxaluria and Kidney Stone Risk.	Tenapanor	basic_science	4	recruiting